David Clements
Psychiatry · Philadelphia, PANPI 1932574118
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,095 of the $4,943 with a category attached, or 62.6%. 17 manufacturers reported payments, led by Medical Device Business Services, Inc. at 35.5% of the total. Among psychiatry clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 198 payments — averaging $24.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$2K
- AbbVie$960
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$896
- Axsome Therapeutics, Inc.$462
- Takeda Pharmaceuticals U.S.A., Inc.$179
- Lundbeck LLC$168
- plus $525 from 11 others
What the payments were for
- Speaking & faculty fees$2004%
- Travel & lodging$1,64733%
- Food & beverage$3,09563%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 7 | $1,753 |
| AbbVie(2 entities) | 53 | $960 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 63 | $896 |
| Axsome Therapeutics, Inc. | 30 | $462 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $179 |
| Lundbeck LLC | 8 | $168 |
| Vanda Pharmaceuticals Inc. | 8 | $145 |
| Neurocrine Biosciences, Inc. | 4 | $75 |
| Collegium Pharmaceutical, Inc. | 3 | $63 |
| Corium, LLC | 2 | $48 |
| Alkermes, Inc. | 2 | $47 |
| Noven Therapeutics, LLC | 3 | $43 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $29 |
| Braeburn Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Bausch Health US, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,943 in reported general payments places this provider in the 90th percentile of 1,838 psychiatry providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Divalproex Sodium ErDivalproex Sodium | 11 | $1,128 |
| Risperidone OdtRisperidone | 18 | $765 |
| Buprenorphine Hcl | 11 | $704 |
| Gabapentin | 62 | $703 |
| Mirtazapine | 38 | $662 |
| Vilazodone Hcl | 11 | $555 |
| Divalproex Sodium | 28 | $414 |
| Bupropion XlBupropion Hcl | 32 | $372 |
| Alprazolam | 46 | $348 |
| Olanzapine | 20 | $335 |
| Diazepam | 23 | $307 |
| Lorazepam | 64 | $301 |
| Prazosin Hcl | 23 | $266 |
| Escitalopram Oxalate | 40 | $247 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 14 | $222 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Philadelphia
- Daniel WeintraubPhiladelphia$647K
- Michael ThasePhiladelphia$396K
- Freddy AliPhiladelphia$107K
- Richard JaffePhiladelphia$101K
- Ramesh EluriPhiladelphia$85K
- John LaurielloPhiladelphia$62K
- Sidra GhafoorPhiladelphia$56K
- Maria OquendoPhiladelphia$50K
- David OslinPhiladelphia$30K
- Bianca PrevidiPhiladelphia$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.